Skip to main navigation
Skip to search
Skip to main content
University of Edinburgh Research Explorer Home
Help & FAQ
Home
Research output
Profiles
Research units
Projects
Datasets
Prizes
Activities
Press/Media
Equipment
Search by expertise, name or affiliation
11β-Hydroxysteroid Dehydrogenases and Hypertension in the Metabolic Syndrome
Matthew A. Bailey
Deanery of Clinical Sciences
Centre for Cardiovascular Science
Research output
:
Contribution to journal
›
Article
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of '11β-Hydroxysteroid Dehydrogenases and Hypertension in the Metabolic Syndrome'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Pharmacology, Toxicology and Pharmaceutical Science
Bioavailability
14%
Cardiovascular Disease
14%
Clinical Study
14%
Comorbidity
14%
Dyslipidemia
14%
Glucocorticoid
100%
Glucocorticoid Receptor
14%
Hydrocortisone
14%
Hydroxysteroid Dehydrogenase
100%
Insulin Resistance
14%
Malignant Neoplasm
14%
Metabolic Syndrome X
100%
Mineralocorticoid Receptor
14%
Non Insulin Dependent Diabetes Mellitus
14%
Nonalcoholic Fatty Liver
14%
Oxidoreductase
14%
Preclinical Study
14%
Prevalence
14%
Table Salt
42%
Biochemistry, Genetics and Molecular Biology
Blood Pressure
14%
Comorbidity
14%
Cortisol
14%
Dyslipidemia
14%
Glucocorticoid
100%
Glucocorticoid Receptor
14%
Hydroxysteroid Dehydrogenase
100%
Insulin Resistance
14%
Mineralocorticoid Receptor
14%
Oxidoreductase
14%
Preclinical Study
14%
Prevalence
14%
Sodium Retention
14%
Vascularization
14%